Ocugen has developed a new platform that could help bring greater attention to underserved areas of ophthalmology.

With a $9 million grant, Inovio Pharmaceuticals is testing a unique immunotherapy approach to defeat the outbreak.

Repisodic has developed a technology solution to help patients and their families make smarter, faster decisions about post-acute care.

With a $100 million investment, MRA Group hopes to turn the suburban research campus into an energy-efficient innovation hub.

The local company is developing solutions that can improve treatment and outcomes for cancer patients.

Einstein Medical Center is one of the first hospitals in the nation to allow visitors to register to vote with kiosks on site.

According to these five predictions, including officially killing the advice that women “lean in,” the fight for equity at work is only gaining steam.

Independence Health Group CEO and Chamber of Commerce chairman Dan Hilferty shares his forecast for the growth of the region’s bustling health care ecosystem.

She tells us what it’s like babysitting drunks when she’s totally sober and explains why “Bohemian Rhapsody” might not be the best song to sing on a busy karaoke night.

The company wants to eradicate suicide by creating technologies that improve the bond between mental health patients and their providers.

It is the first baby born as part of Penn Medicine’s ongoing trial to help women give birth following uterus transplantation.

Patients can access the testing service to determine how they might respond to various psychiatric drugs.

Verix Health is developing a suite of steerable surgical needles to enable minimally invasive treatment of hard-to-reach cancer tumors.

From pivotal clinical trials to major partnerships, these five Philly companies made the most of 2019. Here’s what they’ve got planned for 2020.